chrX-102749170-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001142524.2(GPRASP3):āc.175A>Gā(p.Lys59Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000127 in 1,098,248 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001142524.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRASP3 | NM_001142524.2 | c.175A>G | p.Lys59Glu | missense_variant | 4/4 | ENST00000457056.6 | |
ARMCX5-GPRASP2 | NR_146584.3 | n.1218+28079A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRASP3 | ENST00000457056.6 | c.175A>G | p.Lys59Glu | missense_variant | 4/4 | 4 | NM_001142524.2 | P1 | |
ARMCX5-GPRASP2 | ENST00000652409.1 | c.175A>G | p.Lys59Glu | missense_variant | 8/8 | P1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000546 AC: 10AN: 183071Hom.: 0 AF XY: 0.0000444 AC XY: 3AN XY: 67573
GnomAD4 exome AF: 0.0000127 AC: 14AN: 1098248Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 4AN XY: 363604
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.175A>G (p.K59E) alteration is located in exon 4 (coding exon 1) of the BHLHB9 gene. This alteration results from a A to G substitution at nucleotide position 175, causing the lysine (K) at amino acid position 59 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at